SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-213690
Filing Date
2020-08-07
Accepted
2020-08-07 20:34:31
Documents
2
Group Members
BLACKSTONE CLARUS III L.L.C.BLACKSTONE GROUP INC.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I/II GP L.L.C.CLARUS LIFESCIENCES III, L.P.CLARUS VENTURES III GP, L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D d90191dsc13d.htm SC 13D 161721
2 EXHIBIT A d90191dex99a.htm EX-99.A 19511
  Complete submission text file 0001193125-20-213690.txt   183036
Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Holdings II L.P. (Filed by) CIK: 0001484870 (see all company filings)

IRS No.: 260288604
Type: SC 13D

Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Subject) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91583 | Film No.: 201086540
SIC: 2834 Pharmaceutical Preparations